May 17 | 17:15-18:15 | Studio A
Moderator : Nieves Gonzalo
Anchorperson: Jean Fajadet
Speakers: Javier Escaned, Billal Patel, Dariusz Dudek, Jeffrey Moses
Our solutions support interventionalists in minimizing the contrast-load for the patient and physicians, and in performing interventional procedures with clarity and confidence, improving cardiac care experiences for staff and patients. Join our training village at EuroPCR and learn more.
Product availability is subject to country regulatory clearance. Please contact your local sales representative to check availability in your country.
IntraSight Mobile is an easy-to-use, small footprint, IVUS imaging and physiology system, designed for coronary and peripheral vascular procedures, operable directly from the sterile field.
Most cardiac patients fall under high-risk category for acute kidney injury (AKI) 1
Helps to strengthen and streamline communication and collaboration, delivers automated anatomical insights, enables simultaneous visualization of devices, soft tissue and 3D imaging, and supports an advanced fusion imaging workflow.
Philips Azurion is the next generation image-guided therapy platform that allows you to easily and confidently perform procedures with a unique user experience, helping you optimise your lab performance and provide superior care.
Philips introduces the Interventional Hemodynamic system (Hemo system) which brings advanced hemodynamic measurements to the cath lab. Integrated with the market leading IntelliVue X3 patient monitor, this unique combination enables continuous patient monitoring throughout the cath lab.
The IntelliVue X3 portable monitor stays connected to the patient for consistent physiological monitoring and timely detection of potential adverse events during every stage of their journey.
Sign up to receive news and updates on our new innovations in cardiology that deliver clinical confidence and efficiency in the diagnosis and treatment in CAD and SHD.
Coronary diagnostic for Complex PCI
Joost Maltha Joost.firstname.lastname@example.org Philips Global Press Office Tel: +31 6 10 55 8116
Philips Global Press Office
Tel: +31 6 10 55 8116
We are always interested in engaging with you.
Let us know how we can help.
1 Mehran R, Aymong ED, Nikolsky E, et al. A simple risk score for prediction of contrast induced nephropathy after percutaneous coronary intervention: development and initial validation. J Am Coll Cardiol. 2004; 44(7): 1393-1399. doi:10.1016/j.jacc.2004.06.068.
You are about to visit a Philips global content pageContinue
You are about to visit the Philips USA website.I understand
Our site can best be viewed with the latest version of Microsoft Edge, Google Chrome or Firefox.